Reading time is 1 mins


President of the Turkish Vaccine Institute and Member of the Scientific Council on Coronavirus Prof. Doctor:

The initial data are very positive. Among the who underwent TURKOVAC, there was no one who had severe COVID-19. The domestic vaccine also rapidly raised antibody levels. It can also be easily used as a third-dose vaccine

President of the Turkish Vaccination Institute and Member of the Scientific Committee on Coronavirus of the Ministry of Health Prof. Dr. evaluated the preliminary results obtained in clinical trials conducted on the domestic inactive COVID-19 vaccine TURKOVAC. To note that the data of the TURKOVAC vaccine in clinical trials were quite positive, and positive results were also obtained from comparative data conducted with the inactive vaccine Sinovac.

Black, TURKOVAC applied between persons covid – 19 heavy-pass rapidly raise antibody levels should also receive the vaccine when Native saying, “This is the effectiveness of the vaccine, showing an advantage in terms of retention. At this point, our initial data are very positive. All of these data were submitted to the commissions evaluating the emergency use approval in detail. He is being evaluated very carefully.

During the production process, “stability” tests were performed to determine whether the amount of antigen in the vaccine was sufficient for the body and the expiration date. If TURKOVAC receives approval, it may be written on it that “It has a 3-month use period”. According to the results of stability tests, it can increase to 6 months. As a result of tests that will last for several years, the duration of use can also be determined as 1 or 2 years.

If the production, undesirable effects, and effectiveness are evaluated as ‘appropriate’ in the examinations conducted, mRNA can be made if desired in our country right now, inactive Sinovac vaccine can be made if desired, and TURKOVAC can also be easily used as a third vaccine. Anyone who wants to can also choose TURKOVAC as a vaccine dose,” he said.


Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.


Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.


Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.


Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)